Highlights noncoronary structural changes, including PTH-dependent fibrosis and blood pressure-independent LVH, as key contributors to cardiac dysfunction in uremia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to non-hemodynamic remodeling in uremia; leaves open whether PTH targeting improves cardiac outcomes in CKD.
While coronary heart disease is undoubtedly a major cause of cardiac morbidity and mortality in uremia, important noncoronary problems contribute to the common presence of cardiac problems. Based on clinical and experimental studies, we could show: (i) Left ventricular hypertrophy (LVH) can be dissociated, at least in part, from elevation of blood pressure. (ii) In uremia, PTH-dependent intermyocardiocytic fibrosis occurs; it may account, at least in part, for disturbed LV compliance and contribute to the arrhythmogenic potential. (iii) Blood pressure-independent abnormalities of intracardiac arterioles and reduced myocardial capillary supply are observed.
No takes yet. Share an insight, caveat, or question.
Rambausek et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: